Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry

被引:0
|
作者
Corica, B. [1 ]
Romiti, G. F. [1 ]
Proietti, M. [2 ]
Mei, D. A. [1 ]
Boriani, G. [3 ]
Chao, T. F. [4 ]
Olshansky, B. [5 ]
Huisman, M. V. [6 ]
Lip, G. Y. H. [1 ]
机构
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Univ Modena & Reggio Emilia, Modena, Italy
[4] Taipei Vet Gen Hosp, Taipei, Taiwan
[5] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[6] Aalborg Univ, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
    Huisman, Menno, V
    Teutsch, Christine
    Lu, Shihai
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang-Sheng
    Rothman, Kenneth J.
    Lohmann, Ragna
    Gurusamy, Venkatesh Kumar
    Bartels, Dorothee B.
    Lip, Gregory Y. H.
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (05) : 548 - 559
  • [22] A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics
    Huisman, M. V.
    Diener, H. -C.
    Dubner, S. J.
    Halperin, J. L.
    Rothman, K. J.
    Ma, C. -S.
    Lu, S.
    Paquette, M.
    Teutsch, C.
    Franca, L. R.
    Zint, K.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 825 - 825
  • [23] Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Ding, Wern Yew
    Fawzy, Ameenathul Mazaya
    Romiti, Giulio Francesco
    Proietti, Marco
    Pastori, Daniele
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (01) : 39 - 49
  • [24] Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Wern Yew Ding
    Ameenathul Mazaya Fawzy
    Giulio Francesco Romiti
    Marco Proietti
    Daniele Pastori
    Menno V. Huisman
    Gregory Y. H. Lip
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 39 - 49
  • [25] Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Wern Yew Ding
    Ameenathul Mazaya Fawzy
    Giulio Francesco Romiti
    Marco Proietti
    Daniele Pastori
    Menno V. Huisman
    Gregory Y. H. Lip
    Ameenathul Mazaya Fawzy
    Journal of Thrombosis and Thrombolysis, 2024, 57 (1) : 178 - 178
  • [26] POLYPHARMACY IN A GLOBAL COHORT OF PATIENTS TAKING ANTICOAGULANTS FOR ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY
    Button, Dana
    Bayer, Valentina
    Olshansky, Brian
    Larsen, Peter
    Teutsch, Christine
    Patel, Sagar
    Huisman, Menno
    Lip, Gregory
    Kea, Bory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1504 - 1504
  • [27] Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry
    Bayer, Valentina
    Kotalczyk, Agnieszka
    Kea, Bory
    Teutsch, Christine
    Larsen, Peter
    Button, Dana
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Olshansky, Brian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [28] Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry
    Lam, Steven Ho Man
    Romiti, Giulio Francesco
    Corica, Bernadette
    Bucci, Tommaso
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (02):
  • [29] Implications of renal function on adverse clinical events in patients with atrial fibrillation: a comparative analysis of VKA and NOAC therapy - Insights from the GLORIA-AF Registry Phase III
    Liu, Y.
    Chen, Y.
    Lam, S. H. M.
    Huang, B.
    Chao, T. F.
    Olshansky, B.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY
    McIntyre, William F.
    Conen, David
    Olshansky, Brian
    Halperin, Jonathan
    Hayek, Emil
    Huisman, Menno
    Lip, Gregory
    Lu, Shihai
    Healey, Jeff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 413 - 413